Related Experiment Video
Updated: May 17, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
NRTI backbone in HIV treatment: will it remain relevant?
Randall Tressler1, Catherine Godfrey
1HJF, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MA 20892, USA.
Drugs
|October 23, 2012
Summary
Nucleoside reverse transcriptase inhibitors (NRTIs) are vital for HIV treatment and prevention, but resistance and toxicity pose challenges. Developing new NRTIs and strategies to combat resistance is crucial for their future relevance.
Area of Science:
- Virology
- Pharmacology
- Infectious Diseases
Background:
- Nucleoside reverse transcriptase inhibitors (NRTIs) are a cornerstone of antiretroviral therapy (ART) for HIV infection.
- They are essential for initial HIV treatment and preventing mother-to-child transmission, especially in resource-limited settings.
- However, NRTI use is constrained by potential toxicities and the emergence of drug resistance.
Purpose of the Study:
- To review the principal NRTIs, their mechanisms of action, and associated toxicities.
- To discuss the challenges posed by NRTI resistance, including its potential impact from pre-exposure prophylaxis (PrEP).
- To explore the future relevance of NRTIs in HIV management.
Main Methods:
- Literature review of NRTIs, their efficacy, resistance patterns, and toxicities.
- Analysis of the impact of current and potential future uses of NRTIs on resistance.
- Discussion of ongoing research into NRTI-sparing regimens and novel NRTI development.
Main Results:
- NRTIs are effective and affordable but face limitations due to resistance and toxicity.
- The increasing prevalence of resistant HIV strains necessitates new therapeutic agents and targets.
- The widespread use of PrEP may significantly influence NRTI resistance patterns globally, particularly in regions with HIV subtype C predominance.
Conclusions:
- NRTIs may decline in importance unless strategies to mitigate resistance and develop novel agents with reduced toxicity and unique resistance profiles are implemented.
- Ongoing studies on NRTI-sparing regimens are critical for future HIV treatment paradigms.
- Addressing NRTI resistance is paramount to maintaining the long-term efficacy of HIV therapy.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...